Skip to main content
logo
Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
88.70
+14.18 (19.03%)
At close: Jul 22, 2026, 4:00 PM EDT
88.37
-0.33 (-0.37%)
Pre-market: Jul 23, 2026, 8:25 AM EDT

Arrowhead Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Cap
12,4944,6802,4092,8833,5026,513
Market Cap Growth
439.79%94.27%-16.45%-17.66%-46.23%47.75%
Enterprise Value
12,0964,6532,6152,8793,2276,171
Last Close Price
88.7034.4919.3726.8733.0562.43
Forward PE
-140.94140.94140.94140.94140.94
PS Ratio
20.095.64678.4511.9814.4047.10
PB Ratio
20.3110.1013.1910.638.7915.93
P/TBV Ratio
20.3210.0212.8810.999.0116.39
P/FCF Ratio
-29.83---44.08
P/OCF Ratio
-26.07---38.02
EV/Sales Ratio
19.455.61736.4011.9613.2744.62
EV/EBITDA Ratio
-38.06----
EV/EBIT Ratio
-47.32----
EV/FCF Ratio
-29.66---41.77
Debt / Equity Ratio
2.281.444.431.300.190.06
Debt / EBITDA Ratio
-6.00----
Debt / FCF Ratio
-4.68---0.17
Net Debt / Equity Ratio
2.00-0.101.08-0.07-0.74-0.84
Net Debt / EBITDA Ratio
-6.04-0.39-0.340.111.752.43
Net Debt / FCF Ratio
-24.09-0.30-0.330.061.56-2.32
Asset Turnover
0.320.660.000.330.350.22
Quick Ratio
0.554.026.343.832.722.58
Current Ratio
6.234.866.743.952.922.62
Return on Equity (ROE)
-46.81%8.67%-254.98%-59.33%-42.67%-32.36%
Return on Assets (ROA)
-12.35%4.55%-62.81%-28.51%-26.02%-24.18%
Return on Invested Capital (ROIC)
-15.92%13.60%-182.56%-106.40%-191.92%-127.38%
Return on Capital Employed (ROCE)
-13.74%8.83%-70.85%-33.80%-31.97%-28.51%
FCF Yield
-3.35%---2.27%
Buyback Yield / Dilution
-9.83%-11.67%-12.21%-1.26%-1.62%-3.00%
Total Shareholder Return
-9.83%-11.67%-12.21%-1.26%-1.62%-3.00%
SEC Filings: 10-K · 10-Q